Preliminary efficacy and safety of acetyl-CoA carboxylase inhibitor GS-0976 in patients with compensated cirrhosis due to NASH — S. Harrison (2018) | RDL Network
Stephen A. Harrison, Mazen Noureddin, Robert Herring, Peter Ruane, B. Mccolgan, Macky Natha, Brian J. Kirby, Cara Nelson, Raúl Antonio Aguilar Vera, Catherine Jia, Mani Subramanian, Robert P. Myers, Michael S. Middleton, Claude B. Sirlin, Mark Fitch, Kelvin W. Li, Marc Hellerstein, Eric Lawitz
Eric Lawitz, Angie Coste, Fred Poordad, Naim Alkhouri, Nicole Loo, B. Mccolgan, Jacqueline M. Tarrant, Tuan Nguyen, Ling Han, Chuhan Chung, Adrian S. Ray, John G. McHutchison, G. Mani Subramanian, Robert P. Myers, Michael S. Middleton, Claude B. Sirlin, Rohit Loomba, Edna Nyangau, Mark Fitch, Kelvin W. Li, Marc Hellerstein
Mohamad Dandan, Julia Han, Sabrina A Mann, Rachael Kim, Kelvin W. Li, Hussein Mohammed, Jen‐Chieh Chuang, Kaiyi Zhu, Andrew N. Billin, Ryan S. Huss, Chuhan Chung, Robert P. Myers, Marc Hellerstein
Eric Lawitz, Edward Gane, Peter Ruane, Robert Herring, Ziad Younes, Paul Y. Kwo, Jie Zhang, Catherine Jia, Jay Chuang, B. Mccolgan, Chuhan Chung, Mani Subramanian, Robert P. Myers, Michael S. Middleton, Kelvin W. Li, Marc Hellerstein, Mazen Noureddin, Stephen A. Harrison, Rohit Loomba
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.